Skip to main content
. 2018 Apr 19;2018:1415062. doi: 10.1155/2018/1415062

Table 2.

Lesion characteristics.

FNA (n = 51) FNB (n = 43) p
Location of lesion in pancreas, n (%) 0.275
 Head 27 (52.9) 31 (72.1)
 Uncinate 5 (9.8) 2 (4.7)
 Genu 3 (5.9) 3 (7.0)
 Body 8 (15.7) 5 (11.6)
 Tail 8 (15.7) 2 (4.7)
Lesion size (largest dimension, mm) 0.787
 Missing, n (%) 1 (2.0) 5 (11.6)
 Median (IQR) 26.0 (18.0, 34.0) 26.0 (18.0, 36.0)
 Mean (SD) 26.8 (12.8) 27.4 (11.5)
 Range (5.0, 70.0) (9.0, 55.0)
Cytologic/histologic diagnosis 0.468
 Nondiagnostic 2 (3.9) 0 (0.0)
 Benign 3 (5.9) 5 (11.6)
 Atypical 2 (3.9) 4 (9.3)
 Suspicious 5 (9.8) 5 (11.6)
 Malignant 39 (76.5) 29 (67.4)
Final diagnosis 0.018
 Pancreatic adenocarcinoma 37 (72.5) 31 (72.1)
 Neuroendocrine tumour 12 (23.5) 4 (9.3)
 Inflammatory 0 (0.0) 4 (9.3)
 Lymphoma 0 (0.0) 1 (2.3)
 Benign/normal 2 (3.9) 1 (2.3)
 Other 0 (0.0) 2 (4.7)

FNA = fine needle aspiration; FNB = fine needle biopsy; IQR = interquartile range; SD = standard deviation.